Literature DB >> 219840

Studies on the polypeptides of poxvirus. I. Comparison of structural polypeptides in vaccina, cowpox and Shope fibroma viruses.

K Ikuta, H Miyamoto, S Kato.   

Abstract

Radioactively labeled vaccinia, cowpox and Shope fibroma virions free from any detectable contamination with host cell protein, were dissociated into their constituent polypeptides, and these were then analyzed by SDS-polyacrylamide gel electrophoresis and autoradiography. The profiles of constituent polypeptide bands of four strains of vaccinia virus (IHD-W, IHD-J, Lister and DIs) were almost the same, except that a polypeptide of about 41,000 daltons was not detectable in the autoradiogram of strain IHD-W which has no hemagglutinin. The profile of polypeptide bands of cowpox virions was also almost the same as that of vaccinia virions, except for several polypeptides of about 40,000 to 50,000 daltons, but the profile of Shope fibroma virions differed considerably from that of vaccinia or cowpox virions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 219840

Source DB:  PubMed          Journal:  Biken J        ISSN: 0006-2324


  7 in total

1.  Comparison of contagious ecthyma virus genomes by restriction endonucleases.

Authors:  F Rafii; D Burger
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

2.  Biochemical and electron microscopic studies of the replication and composition of milker's node virus.

Authors:  V Thomas; L Flores; J A Holowczak
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

3.  Partial antigenic characterization of buffalopox virus.

Authors:  P Anand Kumar; G Butchaiah
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

4.  Polypeptide analysis with monoclonal antibodies of A type inclusion bodies induced by cowpox virus.

Authors:  N Kitamoto; S Tanimoto; K Hiroi; T Tanaka; H Miyamoto; N Wakamiya; K Ikuta; S Ueda; S Kato
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  Feasibility of UV-inactivated vaccinia virus in the modification of tumor cells for augmentation of their immunogenicity.

Authors:  N Wakamiya; Y L Wang; H Imai; H X Gu; S Ueda; S Kato
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

6.  Cross-reactivity among cowpox, ectromelia and vaccinia viruses with monoclonal antibodies recognizing distinct antigenic determinants in A-type inclusion bodies.

Authors:  N Kitamoto; S Tanimoto; K Hiroi; H Miyamoto; N Wakamiya; S Ueda; S Kato
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

7.  Tumor cells treated with vaccinia virus can activate the alternative pathway of mouse complement.

Authors:  N Wakamiya; N Okada; Y L Wang; T Ito; S Ueda; S Kato; H Okada
Journal:  Jpn J Cancer Res       Date:  1989-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.